Supplemental material
Pathogens and Global Health
Volume 111, 2017 - Issue 1
Open access
2,710
Views
18
CrossRef citations to date
0
Altmetric
Original Article
Toxoplasmic encephalitis relapse rates with pyrimethamine-based therapy: systematic review and meta-analysis
Mark P. ConnollyUnit of PharmacoEpidemiology & PharmacoEconomics, Department of Pharmacy, University of Groningen, Groningen, The Netherlands;Health Economics, Global Market Access Solutions LLC, Mooresville, NC, USACorrespondence[email protected]
, Elizabeth GoodwinMedical Affairs, Turing Pharmaceuticals, New York, USA
, Carina ScheyUnit of PharmacoEpidemiology & PharmacoEconomics, Department of Pharmacy, University of Groningen, Groningen, The Netherlands;Health Economics, Global Market Access Solutions LLC, Mooresville, NC, USA
& Jacqueline ZummoMedical Affairs, Turing Pharmaceuticals, New York, USA
Pages 31-44
|
Published online: 16 Jan 2017
Related Research Data
Toxoplasmic encephalitis relapse rates with pyrimethamine-based therapy: systematic review and meta-analysis
Source:
Figshare
Toxoplasmic encephalitis relapse rates with pyrimethamine-based therapy: systematic review and meta-analysis
Source:
Figshare
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.